IL-17, secreted by Th17, contributes to the immunosuppressive environment within tumors by inducing vascular endothelial growth factor (VEGF) expression and promoting the differentiation of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment. This evidence concerns the gene IL17A and neoplasm.